Prasugrel shows advantage over ticagrelor in diabetic patients after stent placement
One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors-ticagrelor or prasugrel-in people with Type…
Effectiveness of anti-clotting meds after stent placement varied in people with diabetes
Research Highlights:
Two P2Y12 inhibitors often used interchangeably, ticagrelor and prasugrel (antiplatelet medications prescribed to prevent the…